Publications by authors named "K Venter"

Claim this Profile
H
H-NMR-based metabolomics study of Rifafour in a healthy Kramnik (C3HeB/FeJ) tuberculosis mouse model.
Oluwadara Pelumi Omotayo, Siyethemba Bhengu, Yolandy Lemmer, Kobus Venter, Shayne Mason

Front Pharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transarterial chemoembolization outcomes for advanced hepatocellular carcinoma sorafenib and best supportive care in a sub-Saharan African cohort.
Sanju Sobnach, Karla Christina Sousa Silva, Ebtesam Abdel-Rashid Abdel-Shafy, Muhammad Emmamally, Catherine Wendy Spearman, Keith Venter

World J Gastroenterol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying the optimal dose of cannabidiol by intrabuccal administration in Kramnik (C3HeB/FeJ) mice.
Oluwadara Pelumi Omotayo, Siyethemba Bhengu, Kobus Venter, Yolandy Lemmer, Shayne Mason

Animal Model Exp Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presentation, treatment and long-term outcomes of hepatocellular carcinoma in patients with and without HIV: a comparative observational cohort study.
Sanju Sobnach, Muhammad Emmamally, Keith Venter, C Wendy Spearman, Inae Kim

HPB (Oxford)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare Disparities in the Treatment and Outcomes of Hepatocellular Carcinoma in South Africa.
Sanju Sobnach, Muhammad Emmamally, Keith Venter, Jake Krige, Marc Bernon

World J Surg· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis